Abstract. The present study explored the modulatory potential of hydrochlorothiazide and triamterene on resistant hypertension patients. The mechanistic information for resistant hypertension was explored by studying the pressure-natriuresis curves between the salt sensitive population and non-salt sensitive population. A cohort of 23 patients with non-hypertension (NH) (13 males and 10 females; aged from 23 to 62 years), 26 patients with controlled hypertension (CH) (14 males and 12 females; aged from 19 to 72 years) and 23 patients with resistant hypertension (RH) (13 males and 10 females; aged from 19 to 76 years) were selected. The patients were divided into two main groups on the basis of salt sensitivity viz. salt sensitive (SS) and non-SS (NSS) groups. These two groups were further classified into four subgroups based on the diuretic drug used. Hydrochlorothiazide-treated subgroups were named as salt sensitive hydrochlorothiazide (SSHy) and non-SSHy (NSSHy) groups. Similarly, triamterene-treated subgroups were named as salt sensitive triamterene (SSTr) and non-SSTr (NSSTr) groups. Treatment continued for 2 weeks and the pressure-natriuresis curves were recorded. Additionally, the plasma aldosterone and renin activity was monitored by radioimmunoassay. The pressure-natriuresis curves of the SS group were shifted towards the right relative to NSS group. On the other hand, hydrochlorothiazide and triamterene treatments reversed the changes of pressure-natriuresis curves. Moreover, significant differences were observed among various important indices including plasma aldosterone, renin activity, office blood pressure as evaluated by the chronic salt load test and diuretic intervention tests. The study concludes that hydrochlorothiazide and triamterene hold good potential as an efficient modulator of resistive hypertension.
Introduction
The cardiovascular disease burden worldwide is highly influenced by the major risk factor of hypertension (1) . Hypertension is a pathological state responsible for sudden death, stroke, coronary heart disease, heart failure, auricular fibrillation, peripheral vascular disease, and renal insufficiency (2, 3) . In China, the number of positive patients with hypertension is more than 330 million and in every 3 adults, there is one with hypertension (4,5). The major causative factor responsible for this is a high salt diet and salt sensitivity (6) . Salt sensitivity is basically a clinical observation of alterations in blood pressure of the patient with respect to his/her salt intake (7) . Moreover, salt sensitive individuals are also affected by endothelial dysfunction, which may be an important contributor of cardiovascular risks of salt sensitive hypertension (8) .
Resistant hypertension is the extreme pathological state wherein more than four mediations including diuretic are engaged in order to control blood pressure (9) . A diuretic is an indispensable antihypertensive drug utilized worldwide for the treatment of hypertension (10) . However, a long-term large-dose administration of diuretics would affect the glucose, lipid metabolism and electrolyte; thus, its role as a first-line antihypertensive drug is limited to some extent. Consequently, the selection of an effective diuretic as well as proper dose is crucial in these cases. Moreover, there is no scientific evidence in evidence-based medicine as to how to choose proper and effective diuretics, especially in the cases of resistant hypertension.
The present study investigated the influences of different diuretics on pressure-natriuresis curves of resistant hypertension patients, in order to provide a research basis for improving the individualized new drug and non-drug therapies for resistant hypertension. Screening. Screening and treatment of the possible pathogeny of hypertension was performed by using modern diagnosis and treatment technology to screen and exclude secondary hypertension, including renal parenchyma, renal vascular, primary hyperaldosteronism, sleep apnea syndrome and pheochromocytoma.
Materials and methods

Experimental
Acute and chronic salt load tests. The improvised short method was used, which included dripping of 2,000 ml normal saline into the patients, which was immediately followed by the administration of 40 mg furosemide. After 2 h, blood pressure was recorded. This was followed by calculation of growth rate between salt load mean pressure and baseline pressure, and the decreasing rate between mean blood pressure (MBP) (2 h after furosemide) and baseline pressure, the sum of the two values ≥15 mmHg was considered to be salt sensitive. On the other hand, a decreasing rate <5 mmHg was considered to be salt resistive. Balanced diet (9 g/day, 150 mmol/day Na) x 7 days, 3 g salt in each meal viz. breakfast, lunch and dinner each; then low salt diet (3 g/day, 51.3 mmol/day Na + ) x 7 days, 1 g salt in each meal viz. breakfast, lunch and dinner each; immediately followed by high salt diet (18 g/day, 307.7 mmol/day Na + ) x 7 days, 3 g salt for breakfast and 7.5 g salt for lunch and dinner. We monitored the 24 h ABP, office blood pressure, aldosterone, 24 h natriuresis, 24 h kaliuresis, PWA and PWV. Salt sensitivity was calculated by finding the SSI according to MBP in low salt period and high salt period. SSI = (MBPHs -MBPLs)/MBPLs, SSI >5% was considered to be SS; where SSI <5% was considered to be salt resistant (SR). According to the SSI, the subjects were divided into SS and non-SS (NSS) groups. Then according to complete random design, the patients were further divided into with hypertension salt sensitivity and hypertension nonsalt sensitivity into SSHy, SSTr, NSSHy and NSSTr groups. Patients received oral administration of diuretic for two weeks in high salt diet period. During chronic salt load test period, we monitored the 24 h natriuresis/kaluresis, serum sodium/potassium, cortisol, plasma aldosterone, renin activity, office blood pressure, 24 h ABP, PWA and PWVcf at day 7 during low salt diet period, balanced salt diet period, high salt diet period and diuretic intervention period. Then the pressure-natriuresis curve was drawn based on the results of chronic salt load test.
Radioimmunoassays and other immune assays. All the radioimmunoassays and other immune assays were performed by the specific kits as per the supplier protocols.
Results
Screening results of resistant hypertension. From October 2012
to October 2014, a total of 593 patients received hypertension screening and treatment in the Central Hospital of Xuzhou, among whom were 62 cases (10.46%) of resistant hypertension. In the above 62 patients, 55 patients were admitted to hospital and received diagnostic classification and had comprehensively individualized treatment. In the 55 admitted patients, 28 patients (50.90%) were diagnosed with essential resistant hypertension, 12 (21.82%) with essential aldosteronism, 5 (9.09%) with obstructive sleep apnea syndrome, 3 (5.45%) with renal parenchymal hypertension, 5 (9.09%) with renal vascular hypertension (4 atherosclerosis and 1 fibromuscular dysplasia), 1 (1.82%) with Cushing's syndrome, 1 (1.82%) with chromaffinoma, and 0 with aortic constriction, 0 with drug-induced hypertension.
Results of acute salt load test. After the acute salt load test, 7 of 16 cases in the �H group were confi rmed with salt sensithe �H group were confi rmed with salt sensigroup were confirmed with salt sensitivity, and the detection rate was 43.75%; 10 of 20 cases in the CH group were confirmed with salt sensitivity, and the detection rate was 50.00%; 8 of 19 cases in the RH group were confirmed with salt sensitivity, with a detection rate of 42.11% (Table I) .
Results of chronic salt load test.
After the chronic salt load test, 7 of 16 cases in the �H group were confirmed with salt sensitivity, detection rate of 43.75%; 11 of 20 cases in CH group were confirmed with salt sensitivity, detection rate of 55.00%; and 8 of 19 cases in RH group were confirmed with salt sensitivity, with a detection rate of 47.37% (P>0.05) ( Table II) .
Results of diuretic intervention trial.
The NH group received 3-week chronic salt load test, RH and CH groups received 5-week chronic salt load test and diuretic intervention trial. Differences in plasma aldosterone, renin activity, office blood pressure (systolic blood pressure, diastolic blood pressure, mean arterial pressure), 24 h ABP, central aortic pressure, and carotid pulse wave conduction velocity among the three groups were observed to be statistically different (P<0.05). The results confirmed the ability of diuretics to change the right shift of the pressure-natriuresis curve (Figs. 1-3 and Table III) .
Discussion
Resistant hypertension is a particular type of hypertension characterized by high baseline, long course, and many combined risk factors (13) . Management of this deadly pathological state involved utilization of 3-4 antihypertensive drugs including diuretics, so as to get the blood pressure of affected patient to normal (14, 15) . However, random employment of diuretics in the management of this pathological state may result in the obstruction of the epithelial sodium channels or reduce the re-absorption of Na + and Cl - (16) . Sensitivity to salt is another key player influencing the use of diuretic therapeutics in resistant hypertension (7, 17) . Salt sensitivity is the key player that helps in achieving resistance to the treatment during resistant hypertension. In the present study, modulatory potential of two antihypertensive drugs, the triamterene and hydrochlorothiazide, have been studied in resistive hypertension patients.
Triamterene is a water pill that has the ability to control the salt absorption by the body and simultaneously keeps the potassium levels in the normal range (18) . It does this by blocking the sodium channels (19) . On the other hand, hydrochlorothiazide is a thiazide medication able to cause decline in the retention of water by kidneys (20) . The combination of these two drugs in the present study, successfully managed resistant hypertensions by resulting in significant improvement in water-sodium retention in the affected patients. Moreover, in the present study, the mechanism of the therapeutic effects of this combination was further studied in a novel way by observation of the pressure-natriuresis curve.
Pressure-natriuresis curve has the ability to show an increase of the resistance of afferent glomerular arteriole, the glomerulotubular imbalance and the increase of sodium reabsorption of kidney tubules. In the present study, salt intake constant deduced from pressure-natriuresis curve indicated the blood pressure sensitivity to salt, which also provided a new hypothesis for the study of the salt sensitivity mechanism (21) . The urine protein excretion rate of the SS group has been observed to be significantly higher than that of the non-SS group, which directly related the urine protein excretion rate to increasing glomerular capillary pressure (22) .
Thus, it is evident from the above observations that the combination of drugs is able to efficiently manage resistant hypertension as indicated by the information recorded in the pressure-natriuresis curve. Use of pressure-natriuresis to check salt sensitivity in patients is a good hypothesis for selecting individual combination of antihypertensive drugs for more efficient treatments with minimal side effects. However, more studies are required in the clinical settings making this approach the gold standard in resistant hypertension patients.
